OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapy in resectable NSCLC: Answering the question or questioning the answer?
Si‐Yang Liu, Weineng Feng, Yi‐Long Wu
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 727-731
Closed Access | Times Cited: 8
Si‐Yang Liu, Weineng Feng, Yi‐Long Wu
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 727-731
Closed Access | Times Cited: 8
Showing 8 citing articles:
Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives
Lucrezia Barcellini, Simone Nardin, G. Sacco, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 652-652
Open Access
Lucrezia Barcellini, Simone Nardin, G. Sacco, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 652-652
Open Access
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer
Zedao Liu, Zhenlin Yang, Junqi Wu, et al.
Cell (2025)
Open Access
Zedao Liu, Zhenlin Yang, Junqi Wu, et al.
Cell (2025)
Open Access
Two decades of advances in clinical oncology — lessons learned and future directions
Susana Banerjee, Christopher M. Booth, Éduardo Bruera, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 11, pp. 771-780
Closed Access | Times Cited: 3
Susana Banerjee, Christopher M. Booth, Éduardo Bruera, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 11, pp. 771-780
Closed Access | Times Cited: 3
Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis
Riona Aburaki, Yu Fujiwara, Kohei Chida, et al.
Cancer Treatment Reviews (2024) Vol. 131, pp. 102833-102833
Closed Access | Times Cited: 2
Riona Aburaki, Yu Fujiwara, Kohei Chida, et al.
Cancer Treatment Reviews (2024) Vol. 131, pp. 102833-102833
Closed Access | Times Cited: 2
Artificial Intelligence in Clinical Trials of Lung Cancer: Current and Future Prospects
Yuhang Zhang, Peimeng You, Ruizhe Liu, et al.
(2024) Vol. 1, Iss. 1, pp. 34-51
Open Access | Times Cited: 1
Yuhang Zhang, Peimeng You, Ruizhe Liu, et al.
(2024) Vol. 1, Iss. 1, pp. 34-51
Open Access | Times Cited: 1
Comprehensive analysis and identification of subtypes and hub genes of high immune response in lung adenocarcinoma
Han Li, Yuting Lei, Xianwen Lai, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access
Han Li, Yuting Lei, Xianwen Lai, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access
Brief Report: Prognostic impact of adjuvant immunotherapy in patients with resectable non-small cell lung cancer following neoadjuvant chemoimmunotherapy
Yichen Dong, Long Xu, Jialiang Wen, et al.
JTO Clinical and Research Reports (2024) Vol. 6, Iss. 1, pp. 100763-100763
Open Access
Yichen Dong, Long Xu, Jialiang Wen, et al.
JTO Clinical and Research Reports (2024) Vol. 6, Iss. 1, pp. 100763-100763
Open Access
Efficacy of neoadjuvant toripalimab plus chemotherapy and the role of dynamic monitoring of plasma cell-free DNA methylation in predicting pathological response in resectable stage IIB-IIIB non-small cell lung cancer (RENAISSANCE study): a prospective phase II trial
Bing Liu, Ye Tao, Minglei Zhuo, et al.
Research Square (Research Square) (2024)
Open Access
Bing Liu, Ye Tao, Minglei Zhuo, et al.
Research Square (Research Square) (2024)
Open Access
